TrianglePUBLICATIONS · 39411812
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2025 Jan 20
- First author
- Slomovitz BM
This record carries publication-notice metadata. Review the notices below before relying on it.
Publication notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2025 Feb 10;43(5):623. doi: 10.1200/JCO-24-02691.
- note
- Source null
- related pmid
- 39693582
- relationship
- Erratum in
Authors and identifiers
- name
- Slomovitz BM
- type
- Author
- name
- Cibula D
- type
- Author
- name
- Lv W
- type
- Author
- name
- Ortaç F
- type
- Author
- name
- Hietanen S
- type
- Author
- name
- Backes F
- type
- Author
- name
- Kikuchi A
- type
- Author
- name
- Lorusso D
- type
- Author
- name
- Dańska-Bidzińska A
- type
- Author
- name
- Samouëlian V
- type
- Author
- name
- Barretina-Ginesta MP
- type
- Author
- name
- Vulsteke C
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Slomovitz BM
- type
- Author
- name
- Cibula D
- type
- Author
- name
- Lv W
- type
- Author
- name
- Ortaç F
- type
- Author
- name
- Hietanen S
- type
- Author
- name
- Backes F
- type
- Author
- name
- Kikuchi A
- type
- Author
- name
- Lorusso D
- type
- Author
- name
- Dańska-Bidzińska A
- type
- Author
- name
- Samouëlian V
- type
- Author
- name
- Barretina-Ginesta MP
- type
- Author
- name
- Vulsteke C
- type
- Author
- bibliography ids
- nci-bib-3fbd53db4b58ee249bd05d84
- book metadata
- content sha256
- 879e2dfc130b67c98ee268dadc0d43df3d225cd811bb642a811ca1d6537c4789
- document type
- citation
- dois
- 10.1200/JCO-24-01887
- electronic publication date
- display
- 2024 Oct 16
- precision
- day
- year
- 2024
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:39411812
- immutable id
- pubmed:39411812@879e2dfc130b67c98ee268dadc0d43df3d225cd811bb642a811ca1d6537c4789
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 3
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 251-259
- volume
- 43
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2025 Feb 10;43(5):623. doi: 10.1200/JCO-24-02691.
- note
- Source null
- related pmid
- 39693582
- relationship
- Erratum in
- outcomes validated
- false
- pmid
- 39411812
- provenance
- batch id
- 3e43afde6f26fc8df6da
- provider
- NCBI PubMed ESummary
- record sha256
- d1a90281bbf218bcfeb79f9ffd2f4b4ba4807c0016ffb10df0fba02d0153e30e
- response sha256
- fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
- retrieved at
- 2026-09-09T23:48:21.145285+00:00
- publication date
- display
- 2025 Jan 20
- precision
- day
- year
- 2025
- publication types
- Journal Article
- Randomized Controlled Trial
- Clinical Trial, Phase III
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors.
Preserved source evidence · Not medical advice